Medical abortion care encompasses the management of various clinical conditions including spontaneous and induced abortion (both viable and non-viable pregnancies), incomplete abortion and intrauterine fetal demise, as well as post-abortion contraception. Medical management of abortion generally involves...
DESCRIPTION: The Joint Task Force on Practice Parameters, which comprises representatives of the American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI), formed a workgroup to review evidence and provide guidance to health care provide...
Corticoesteroides,
Antagonistas de los Receptores Histamínicos,
Antagonistas de Leucotrieno,
Administración Intranasal,
Administración Oral,
Factores de Edad,
Quimioterapia Combinada,
Antagonistas de los Receptores Histamínicos/uso terapéutico,
Antagonistas de Leucotrieno/uso terapéutico,
Rinitis Alérgica Estacional,
Corticoesteroides/administración & dosificación,
Corticoesteroides/uso terapéutico,
Rinitis Alérgica Estacional/diagnóstico,
Rinitis Alérgica Estacional/tratamiento farmacológico
Jones, N. L;
Koletzko, S;
Goodman, K;
Bontems, P;
Cadranel, S;
Casswall, T;
Czinn, S;
Gold, B. D;
Guarner, J;
Elitsur, Y;
Homan, M;
Kalach, N;
Kori, M;
Madrazo, A;
Megraud, F;
Papadopoulou, A;
Rowland, M.
BACKGROUND: Because of the changing epidemiology of Helicobacter pylori infection and low efficacy of currently recommended therapies, an update of the European Society for Paediatric Gastroenterology Hepatology and Nutrition/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition...
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on oral pharmacologic treatment of type 2 diabetes in adults. This guideline serves as an update to the 2012 ACP guideline on the same topic. This guideline is endor...
Ofrecer recomendaciones basadas en la evidencia para la prevención, detección, tratamiento y seguimiento de las queratosis actínicas, con el fin de apoyar al personal de salud en los diferentes niveles de atención, buscando garantizar una atención integral, homogénea, con calidad, equidad y eficien...
Leucemia Linfoide/diagnóstico,
Leucemia Linfoide/terapia,
Leucemia Mieloide/diagnóstico,
Leucemia Mieloide/terapia,
Análisis Citogenético/métodos,
Vincristina/uso terapéutico,
Doxorrubicina/uso terapéutico,
Dexametasona/uso terapéutico,
Mesilato de Imatinib/uso terapéutico,
Dasatinib/uso terapéutico,
Anticuerpos Monoclonales/uso terapéutico,
Quimioterapia Combinada,
Trasplante Homólogo
Gisbert, JP;
Molina-Infante, J;
Amador, J;
Bermejo, F;
Bujanda, L;
Calvet, X;
Castro-Fernández, M;
Cuadrado-Lavín, A;
Elizalde, JI;
Gene, E;
Gomollón, F;
Lanas, Á;
Martín de Argila, C;
Mearin, F;
Montoro, M;
Pérez-Aisa, Á;
Pérez-Trallero, E;
McNicholl, AG.
Helicobacter pylori approximately infect 50% of Spanish population and causes chronic gastritis, peptic ulcer and gastric cancer. Until now, three consensus meetings on H.pylori infection had been performed in Spain (the last in 2012). The changes in the treatment schemes, and the increasing available ev...
Antibacterianos/uso terapéutico,
Inhibidores de la Bomba de Protones/uso terapéutico,
Bismuto/uso terapéutico,
Algoritmos,
Técnica Delphi,
Quimioterapia Combinada,
Gastritis/complicaciones,
Infecciones por Helicobacter,
Helicobacter pylori,
Probióticos,
Inhibidores de la Bomba de Protones,
Recurrencia,
Terapia Recuperativa,
Neoplasias Gástricas,
Úlcera Gástrica,
Insuficiencia del Tratamiento,
Gastritis/tratamiento farmacológico,
Infecciones por Helicobacter/tratamiento farmacológico,
Helicobacter pylori/efectos de los fármacos
Macle, L;
Cairns, J;
Leblanc, K;
Tsang, T;
Skanes, A;
Cox, JL;
Healey, JS;
Bell, A;
Pilote, L;
Andrade, JG;
Mitchell, LB;
Atzema, C;
Gladstone, D;
Sharma, M;
Verma, S;
Connolly, S;
Dorian, P;
Parkash, R;
Talajic, M;
Nattel, S;
Verma, A.
The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in AF management. This 2016 Focused Update deals with: (1) the management of antithrombotic therapy for AF pa...
Anticoagulantes,
Cardiotónicos,
Inhibidores de Agregación Plaquetaria,
Digoxina,
Magnesio,
Síndrome Coronario Agudo/terapia,
Algoritmos,
Anticoagulantes/uso terapéutico,
Apéndice Atrial/cirugía,
Fibrilación Atrial,
Estimulación Cardíaca Artificial,
Cardiotónicos/efectos adversos,
Ablación por Catéter,
Cardiotónicos/administración & dosificación,
Fibrilación Atrial/terapia,
Fibrilación Atrial/complicaciones,
Hemorragia/inducido químicamente,
Hemorragia/prevención & control,
Magnesio/uso terapéutico,
Intervención Coronaria Percutánea,
Inhibidores de Agregación Plaquetaria/uso terapéutico,
Complicaciones Posoperatorias/prevención & control,
Infarto del Miocardio con Elevación del ST/terapia,
Accidente Cerebrovascular/prevención & control,
Enfermedad de la Arteria Coronaria/complicaciones,
Digoxina/administración & dosificación,
Digoxina/efectos adversos,
Quimioterapia Combinada,
Inhibidores del Factor Xa/uso terapéutico,
Fibrinolíticos/uso terapéutico,
Inhibidores del Factor Xa
Singh, J. A;
Saag, K. G;
Bridges Junior, S. L;
Akl, E. A;
Bannuru, R. R;
Sullivan, M. C;
Vaysbrot, E;
McNaughton, C;
Osani, M;
Shmerling, R. H;
Curtis, J. R;
Furst, D. E;
Parks, D;
Kavanaugh, A;
O'Dell, J;
King, C;
Leong, A;
Matteson, E. L;
Schousboe, J. T;
Drevlow, B;
Ginsberg, S;
Grober, J;
St Clair, E. W;
Tindall, E;
Miller, A. S;
McAlindon, T.
OBJECTIVE: To develop a new evidence-based, pharmacologic treatment guideline for rheumatoid arthritis (RA). METHODS: We conducted systematic reviews to synthesize the evidence for the benefits and harms of various treatment options. We used the Grading of Recommendations Assessment, Development and Eval...
Rationale for the guidelines: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. These guidelines provide updated trea...
Rationale for the guidelines: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. There is an urgent need to update tre...
Neisseria gonorrhoeae,
Gonorrea/tratamiento farmacológico,
Farmacorresistencia Microbiana,
Cefixima/administración & dosificación,
Espectinomicina/administración & dosificación,
Ceftriaxona/administración & dosificación,
Gentamicinas/administración & dosificación,
Kanamicina/administración & dosificación,
Tetraciclina/administración & dosificación,
Eritromicina/administración & dosificación,
Povidona Yodada/administración & dosificación,
Nitrato de Plata/administración & dosificación,
Cloranfenicol/uso terapéutico,
Antibacterianos/administración & dosificación,
Quimioterapia Combinada
